title: Effects of a two-month treatment with low oral doses of cyclosporin on renal function.
abstract: To test the effects of short-term therapy with low doses (LD) of cyclosporin A (CsA) in subjects with normal renal function, seven patients receiving CsA to treat psoriasis were studied. Clearances in maximal H2O diuresis were performed to evaluate changes in GFR (CIn), RPF (CPAH) and tubular function before starting CsA (BAS), after 2 days (S1) and 1 month (S2) of oral therapy with 5 mg/kg per day CsA. The study was repeated at the withdrawal of CsA after tapering (S3) and 2 months after the withdrawal (S4). The studies were performed 12 h after the evening dose of CsA. RPF was significantly less than in BAS throughout the therapy and returned almost to basal values in S4. GFR was significantly less than in BAS both in S2 and in S3. In S4, in spite of an increase, GFR was still significantly less than in BAS. Both in S2 and in S3 proximal tubular fractional sodium reabsorption was significantly less than in BAS and, consequently, both sodium delivery to diluting segments and sodium reabsorption in diluting segments increased. Moreover, both in S2 and in S3 fractional sodium reabsorption in diluting segments and free-water generation were greater than in BAS. In S4 tubular function returned almost to basal values. Our data suggest that short-term therapy with low dose CsA impairs renal function; this impairment is not completely reversed after drug withdrawal.
authors.affiliation: Department of Nephrology, II Faculty of Medicine, University of Naples, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Balletta
authors.forename: C
authors.initials: C
authors.lastname: Libetta
authors.forename: G
authors.initials: G
authors.lastname: Fuiano
authors.forename: M
authors.initials: M
authors.lastname: Delfino
authors.forename: B
authors.initials: B
authors.lastname: Brunetti
authors.forename: B
authors.initials: B
authors.lastname: Ungaro
authors.forename: G
authors.initials: G
authors.lastname: Conte
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D003524:Cyclosporins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D007684:Kidney Tubules / Q000503:physiopathology; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D012079:Renal Circulation / Q000187:drug effects
chemical_list: D003524:Cyclosporins